We present an overview of liver transplantation, focusing on contributions that Japanese surgeons have made toward its development and progress, especially improvements in living-donor liver transplantation. Overall timelines of progress made in liver transplantation in Japan are shown in Table 1 .
Both ectopic cadaveric liver transplantation and the first orthotopic cadaveric liver transplantation were performed at Chiba University in 1964 and in 1968, respectively [1] . In 1965, the Japan Society for Transplantation was established, and an advisory panel for transplantation was set up in 1980 (becoming the Japan Society for Liver Transplantation in 1982). However, controversial issues of brain death diagnosis distanced medical institutions from human liver transplants and led them to put their efforts into only doing tests on animals. Ochiai et al. of Chiba University conducted a study on tacrolimus in 1984 striving to develop an oral preparation [2] . Subsequently, Todo et al. played a major role in the clinical validation of liver transplantation performed at the University of Pittsburgh [3] .
The first living-donor liver transplantation in Japan was performed in 1989 at Shimane Medical College. A procedure using a graft of the left lobe with the caudate lobe [4] and posterior segments of the right lobe [5] was developed at The University of Tokyo. A procedure using a single-segment graft for transplantation in children [6] was developed at Kyoto University. While transplantation from a donor with identical or compatible blood type is common for brain-dead donor liver transplantation, an ABO-incompatible donor is often the only option for living-donor liver transplants as well as living-donor kidney transplants. Various efforts have been made to overcome such ABO-incompatible transplantation, e.g., injection therapy with steroids, prostaglandin E1, or gabexate mesilate via the portal vein, or rituximab (anti-CD20 monoclonal antibody) systemic administration [7, 8] . ABO-incompatible blood type is no longer an absolute contraindication to liver transplantation. Also left-lobe grafting is a unique strategy for donor safety [9] , while counterplans for small-for-size graft syndrome to reduce portal venous pressure have been very much explored in Japanese transplant centers [10] .
Because of the potential risk for the living liver donor, only Asian countries which still have a limited number of organ donations after brain death have perfected the skill of living-donor liver transplantation and imaging modalities useful for preoperative vascular and biliary system simulation. Thus far, only one death of a living donor has been reported out of more than 6000 living-donor transplantations performed in Japan [11] .
